APA (7th ed.) Citation

C, M., N, B., N, M., D, P., B, A., G, R., . . . S, S. (2023). Prevalence of anti-beta-1 antibody 6 months after hospitalization for acute heart failure predicts adverse outcome. ESC heart failure, 10(5), 3227. https://doi.org/10.1002/ehf2.14509

Chicago Style (17th ed.) Citation

C, Morbach, et al. "Prevalence of Anti-beta-1 Antibody 6 Months After Hospitalization for Acute Heart Failure Predicts Adverse Outcome." ESC Heart Failure 10, no. 5 (2023): 3227. https://doi.org/10.1002/ehf2.14509.

MLA (9th ed.) Citation

C, Morbach, et al. "Prevalence of Anti-beta-1 Antibody 6 Months After Hospitalization for Acute Heart Failure Predicts Adverse Outcome." ESC Heart Failure, vol. 10, no. 5, 2023, p. 3227, https://doi.org/10.1002/ehf2.14509.